Technical articles focused on the design, development, and commercialization of single-use regulated devices. 

Bobby Schroeder

Robert (Bobby) Schroeder is a Development Engineer at Boyd Technologies. His responsibilities center around helping translate a concept into a marketable product. Bobby holds a degree in Materials Science and Engineering from Rensselaer Polytechnic Institute. He is a competitive fencer, archer, and enjoys playing tennis, throwing axes, and blacksmithing.

Recent Articles

Recent Posts

White Paper: Bridging the Gap from Batch to Continuous Bioprocessing


For years, traditional batch manufacturing has dominated the biopharma industry. Recently, however, continuous bioprocessing has gained traction among biopharma manufacturers. Below is a look at some of the key differences between these two types of bioprocessing and the resources required for each. Finally, this paper will examine the ways that industry regulations have adapted to the advent of continuous bioprocessing and the ways that continuous production has impacted the single-use market.

Read More

6 Filtration Challenges in Downstream Biopharmaceutical Production

In Brief

Membranes and membrane processes are efficient filtration tools in the manufacturing of biopharmaceutical products. These tools continue to evolve in response to new therapies and processing methods. The membranes used in separation and purification are beginning to play an even more important role as market demand for monoclonal antibodies (mAbs) and other gene and cell culture therapies have expanded in recent years. The global mAb therapeutics market is projected to grow from almost US$ 95.6 billion in 2017 to US$ 174.2 billion by 2026.

Read More